DoMark International Inc. (OTCBB: DOMK) (the "Company" or "DoMark"),
through its wholly owned subsidiary, MuscleFoot Inc., is pleased to
announce that it has donated revolutionary Noraxon equipment to Sean
Peña, physio and biomechanics expert to the world’s top track athletes,
to assist in developing his clients ahead of the London 2012 Olympic
Games. In addition to helping his track and field clients, Mr. Peña will
have the opportunity to harness the advanced performance measurement
capabilities of the Noraxon system to aid his world class athletic
clientele from the equestrian, NFL football, and US Olympics and Track &
Field arenas. In combination with patented Barefoot Science technology
by MuscleFoot Inc., which rehabilitates weak foot muscles and improves
athletic performance, the donated Noraxon technology will vastly aid Mr.
Peña in optimizing his clients’ biomechanics and adjusting their
Sean Peña is the personal physio and biomechanics expert for many
of the world’s top track and field athletes. Notable clients who by the
release of this announcement had secured places on the US Olympic team
include Justin Gatlin, Mike Rogers, William Claye, Joel
Brown, and LoLo Jones. Mr. Peña also works with
Olympic hopefuls, Brittany Reese and David Oliver, who
continue to pursue spots on the US team. All of the previously mentioned
athletes are using Barefoot Science insole system to prepare for the
2012 London Olympics.
“Using this high level technology will allow me to improve the
performance and decrease the risk of injuries to my clients by observing
in an utterly accurate way the motion and performance of the athlete.
Along with Barefoot Science, I will be able to fine tune both the
highest level athlete and the average person to correct biomechanics.
Technology like this was previously only available in a clinic or lab
setting and will now be implemented real time towards functional
activities,” said Sean Peña.
The full system consists of a Clinical DTS (wireless EMG) 4-channel,
instrumented treadmill with MyoVideo, and a FDM-SX pressure plate. The
goal of this three component system is to provide complete insight into
the full body mechanics that control the athlete’s gait. This system
measures vertical force and ground reaction forces, underfoot pressure,
temporal and special gait parameters, and provides insight into muscle
innervations, symmetry and coordination. The system’s 2D kinematics
functionality can track height, distance, and angular data. In short,
the Noraxon technology donated by DoMark provides a complete, ‘inside
and out’ picture of what is happening within the human body, and allows
training staff to modify training routines and make performance
adjustments based on real-time intelligent data.
Noraxon systems have recorded an instant decrease of 50% in postural
sway or increase in balance/ stability as well as a significant increase
in major gait related muscle efficiency and strength in subjects tested
after using the patented Barefoot Science insole system. This donation
is part of a drive on the part of MuscleFoot Inc. to demonstrate the
power of Barefoot Science’s patented foot technology as an integral
component of performance enhancement and pain relief for individuals
from across the spectrum of amateur, elite, and professional athletics.
“Donating this piece of technology to Sean will enhance his clients’
performance immensely, and we are pleased to help him attain even more
credibility in his field as one of the top sports physios on the planet
and help his clients to maximize their full potential,” said VP of
Corporate Development, Patrick Johnson.
Barefoot Science is revolutionizing the $223 billion global footwear and
$3.5 billion foot care markets with its patented insole technology. For
over 15 years, Barefoot Science has studied foot biomechanics, as well
as the capabilities of its products to actively stimulate, strengthen,
and restore the foot. This is significant disruptive foot therapy
technology that will revolutionize the foot care industry. Applied
either through an insole placed inside the shoe, or by integration
directly into the design of the shoe, Barefoot Science technology
prevents and rehabilitates a wide range of foot, leg, and back ailments,
and enhances athletic performance. Barefoot Science backs these claims
with a wealth of scientific research and endorsements from thousands of
customers who currently use Barefoot Science insoles.
Follow Sean Peña and the US Olympic candidates mentioned in this
Sean Peña: @spena24
Justin Gatlin: @justingatlin
Mike Rogers: @mickrogers
Joel Brown: @JoelBD
LoLo Jones: @lolojones
Brittany Reese: @DaLJBeast
David Oliver: @doliversub13
William Claye: @illWill18_
About DoMark International Inc.
DoMark is a marketing and management company engaged in owning,
developing, and marketing a variety of patented game changing consumer
products through its wholly owned subsidiaries, SolaWerks, Inc. and
Musclefoot Inc. Solawerks develops and distributes the SolaPad and
SolaCase combined cover and solar charging systems for Apple's iPad and
iPhone. Musclefoot Inc. distributes, markets, and acts as sales agent
for the revolutionary patented foot care system, Barefoot Science. With
a strong commitment to customer service and security, and a proven and
capable marketing team, DoMark intends to expand its marketing
relationships across a far greater product set.
For more information on the DoMark, visit www.domarkintl.com.
For more information on MuscleFoot Inc., visit www.musclefoot.com.
For more information on Barefoot Science products, visit www.barefoot-science.com.
For more information on SolaWerks products, visit www.solawerks.com.
This news release may contain certain forward-looking information. All
statements included herein, other than statements of historical fact,
are forward-looking information and such information involves various
risks and uncertainties. There can be no assurance that such information
will prove to be accurate, and actual results and future events could
differ materially from those anticipated in such information. A
description of assumptions used to develop such forward-looking
information and a description of risk factors that may cause actual
results to differ materially from forward-looking information can be
found in the Corporation's disclosure documents on the SEDAR website at www.sedar.com.
The Corporation does not undertake to update any forward-looking
information except in accordance with applicable securities laws.